Global Insomnia Therapy Market Research Report 2024(Status and Outlook)
Report Overview:
Insomnia is when you aren't sleeping as you should. That can mean you aren't sleeping enough, you aren't sleeping well or you're having trouble falling or staying asleep. For some people, insomnia is a minor inconvenience.
The Global Insomnia Therapy Market Size was estimated at USD 3066.44 million in 2023 and is projected to reach USD 4156.51 million by 2029, exhibiting a CAGR of 5.20% during the forecast period.
This report provides a deep insight into the global Insomnia Therapy market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Insomnia Therapy Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Insomnia Therapy market in any manner.
Global Insomnia Therapy Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Merck & Co.
Sanofi
Pfizer
Takeda Pharmaceutical Company Ltd.
Purdue Pharmaceuticals L.P.
Eisai, Co. Ltd.
Meda Consumer Healthcare
Pernix Therapeutics
Vanda Pharmaceuticals
ECR Pharmaceuticals
Fidia Farmaceutici
Dainippon Sumitomo
Biocodex
Eli Lilly and Company
Ebb Therapeutics
Market Segmentation (by Type)
Non-pharmacological Therapy
Pharmacological Therapy
Market Segmentation (by Application)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Insomnia Therapy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Insomnia is when you aren't sleeping as you should. That can mean you aren't sleeping enough, you aren't sleeping well or you're having trouble falling or staying asleep. For some people, insomnia is a minor inconvenience.
The Global Insomnia Therapy Market Size was estimated at USD 3066.44 million in 2023 and is projected to reach USD 4156.51 million by 2029, exhibiting a CAGR of 5.20% during the forecast period.
This report provides a deep insight into the global Insomnia Therapy market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Insomnia Therapy Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Insomnia Therapy market in any manner.
Global Insomnia Therapy Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Merck & Co.
Sanofi
Pfizer
Takeda Pharmaceutical Company Ltd.
Purdue Pharmaceuticals L.P.
Eisai, Co. Ltd.
Meda Consumer Healthcare
Pernix Therapeutics
Vanda Pharmaceuticals
ECR Pharmaceuticals
Fidia Farmaceutici
Dainippon Sumitomo
Biocodex
Eli Lilly and Company
Ebb Therapeutics
Market Segmentation (by Type)
Non-pharmacological Therapy
Pharmacological Therapy
Market Segmentation (by Application)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Insomnia Therapy Market
- Overview of the regional outlook of the Insomnia Therapy Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Insomnia Therapy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Insomnia Therapy
1.2 Key Market Segments
1.2.1 Insomnia Therapy Segment by Type
1.2.2 Insomnia Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 INSOMNIA THERAPY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Insomnia Therapy Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Insomnia Therapy Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 INSOMNIA THERAPY MARKET COMPETITIVE LANDSCAPE
3.1 Global Insomnia Therapy Sales by Manufacturers (2019-2024)
3.2 Global Insomnia Therapy Revenue Market Share by Manufacturers (2019-2024)
3.3 Insomnia Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Insomnia Therapy Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Insomnia Therapy Sales Sites, Area Served, Product Type
3.6 Insomnia Therapy Market Competitive Situation and Trends
3.6.1 Insomnia Therapy Market Concentration Rate
3.6.2 Global 5 and 10 Largest Insomnia Therapy Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 INSOMNIA THERAPY INDUSTRY CHAIN ANALYSIS
4.1 Insomnia Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF INSOMNIA THERAPY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 INSOMNIA THERAPY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Insomnia Therapy Sales Market Share by Type (2019-2024)
6.3 Global Insomnia Therapy Market Size Market Share by Type (2019-2024)
6.4 Global Insomnia Therapy Price by Type (2019-2024)
7 INSOMNIA THERAPY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Insomnia Therapy Market Sales by Application (2019-2024)
7.3 Global Insomnia Therapy Market Size (M USD) by Application (2019-2024)
7.4 Global Insomnia Therapy Sales Growth Rate by Application (2019-2024)
8 INSOMNIA THERAPY MARKET SEGMENTATION BY REGION
8.1 Global Insomnia Therapy Sales by Region
8.1.1 Global Insomnia Therapy Sales by Region
8.1.2 Global Insomnia Therapy Sales Market Share by Region
8.2 North America
8.2.1 North America Insomnia Therapy Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Insomnia Therapy Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Insomnia Therapy Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Insomnia Therapy Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Insomnia Therapy Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Merck and Co.
9.1.1 Merck and Co. Insomnia Therapy Basic Information
9.1.2 Merck and Co. Insomnia Therapy Product Overview
9.1.3 Merck and Co. Insomnia Therapy Product Market Performance
9.1.4 Merck and Co. Business Overview
9.1.5 Merck and Co. Insomnia Therapy SWOT Analysis
9.1.6 Merck and Co. Recent Developments
9.2 Sanofi
9.2.1 Sanofi Insomnia Therapy Basic Information
9.2.2 Sanofi Insomnia Therapy Product Overview
9.2.3 Sanofi Insomnia Therapy Product Market Performance
9.2.4 Sanofi Business Overview
9.2.5 Sanofi Insomnia Therapy SWOT Analysis
9.2.6 Sanofi Recent Developments
9.3 Pfizer
9.3.1 Pfizer Insomnia Therapy Basic Information
9.3.2 Pfizer Insomnia Therapy Product Overview
9.3.3 Pfizer Insomnia Therapy Product Market Performance
9.3.4 Pfizer Insomnia Therapy SWOT Analysis
9.3.5 Pfizer Business Overview
9.3.6 Pfizer Recent Developments
9.4 Takeda Pharmaceutical Company Ltd.
9.4.1 Takeda Pharmaceutical Company Ltd. Insomnia Therapy Basic Information
9.4.2 Takeda Pharmaceutical Company Ltd. Insomnia Therapy Product Overview
9.4.3 Takeda Pharmaceutical Company Ltd. Insomnia Therapy Product Market Performance
9.4.4 Takeda Pharmaceutical Company Ltd. Business Overview
9.4.5 Takeda Pharmaceutical Company Ltd. Recent Developments
9.5 Purdue Pharmaceuticals L.P.
9.5.1 Purdue Pharmaceuticals L.P. Insomnia Therapy Basic Information
9.5.2 Purdue Pharmaceuticals L.P. Insomnia Therapy Product Overview
9.5.3 Purdue Pharmaceuticals L.P. Insomnia Therapy Product Market Performance
9.5.4 Purdue Pharmaceuticals L.P. Business Overview
9.5.5 Purdue Pharmaceuticals L.P. Recent Developments
9.6 Eisai, Co. Ltd.
9.6.1 Eisai, Co. Ltd. Insomnia Therapy Basic Information
9.6.2 Eisai, Co. Ltd. Insomnia Therapy Product Overview
9.6.3 Eisai, Co. Ltd. Insomnia Therapy Product Market Performance
9.6.4 Eisai, Co. Ltd. Business Overview
9.6.5 Eisai, Co. Ltd. Recent Developments
9.7 Meda Consumer Healthcare
9.7.1 Meda Consumer Healthcare Insomnia Therapy Basic Information
9.7.2 Meda Consumer Healthcare Insomnia Therapy Product Overview
9.7.3 Meda Consumer Healthcare Insomnia Therapy Product Market Performance
9.7.4 Meda Consumer Healthcare Business Overview
9.7.5 Meda Consumer Healthcare Recent Developments
9.8 Pernix Therapeutics
9.8.1 Pernix Therapeutics Insomnia Therapy Basic Information
9.8.2 Pernix Therapeutics Insomnia Therapy Product Overview
9.8.3 Pernix Therapeutics Insomnia Therapy Product Market Performance
9.8.4 Pernix Therapeutics Business Overview
9.8.5 Pernix Therapeutics Recent Developments
9.9 Vanda Pharmaceuticals
9.9.1 Vanda Pharmaceuticals Insomnia Therapy Basic Information
9.9.2 Vanda Pharmaceuticals Insomnia Therapy Product Overview
9.9.3 Vanda Pharmaceuticals Insomnia Therapy Product Market Performance
9.9.4 Vanda Pharmaceuticals Business Overview
9.9.5 Vanda Pharmaceuticals Recent Developments
9.10 ECR Pharmaceuticals
9.10.1 ECR Pharmaceuticals Insomnia Therapy Basic Information
9.10.2 ECR Pharmaceuticals Insomnia Therapy Product Overview
9.10.3 ECR Pharmaceuticals Insomnia Therapy Product Market Performance
9.10.4 ECR Pharmaceuticals Business Overview
9.10.5 ECR Pharmaceuticals Recent Developments
9.11 Fidia Farmaceutici
9.11.1 Fidia Farmaceutici Insomnia Therapy Basic Information
9.11.2 Fidia Farmaceutici Insomnia Therapy Product Overview
9.11.3 Fidia Farmaceutici Insomnia Therapy Product Market Performance
9.11.4 Fidia Farmaceutici Business Overview
9.11.5 Fidia Farmaceutici Recent Developments
9.12 Dainippon Sumitomo
9.12.1 Dainippon Sumitomo Insomnia Therapy Basic Information
9.12.2 Dainippon Sumitomo Insomnia Therapy Product Overview
9.12.3 Dainippon Sumitomo Insomnia Therapy Product Market Performance
9.12.4 Dainippon Sumitomo Business Overview
9.12.5 Dainippon Sumitomo Recent Developments
9.13 Biocodex
9.13.1 Biocodex Insomnia Therapy Basic Information
9.13.2 Biocodex Insomnia Therapy Product Overview
9.13.3 Biocodex Insomnia Therapy Product Market Performance
9.13.4 Biocodex Business Overview
9.13.5 Biocodex Recent Developments
9.14 Eli Lilly and Company
9.14.1 Eli Lilly and Company Insomnia Therapy Basic Information
9.14.2 Eli Lilly and Company Insomnia Therapy Product Overview
9.14.3 Eli Lilly and Company Insomnia Therapy Product Market Performance
9.14.4 Eli Lilly and Company Business Overview
9.14.5 Eli Lilly and Company Recent Developments
9.15 Ebb Therapeutics
9.15.1 Ebb Therapeutics Insomnia Therapy Basic Information
9.15.2 Ebb Therapeutics Insomnia Therapy Product Overview
9.15.3 Ebb Therapeutics Insomnia Therapy Product Market Performance
9.15.4 Ebb Therapeutics Business Overview
9.15.5 Ebb Therapeutics Recent Developments
10 INSOMNIA THERAPY MARKET FORECAST BY REGION
10.1 Global Insomnia Therapy Market Size Forecast
10.2 Global Insomnia Therapy Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Insomnia Therapy Market Size Forecast by Country
10.2.3 Asia Pacific Insomnia Therapy Market Size Forecast by Region
10.2.4 South America Insomnia Therapy Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Insomnia Therapy by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Insomnia Therapy Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Insomnia Therapy by Type (2025-2030)
11.1.2 Global Insomnia Therapy Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Insomnia Therapy by Type (2025-2030)
11.2 Global Insomnia Therapy Market Forecast by Application (2025-2030)
11.2.1 Global Insomnia Therapy Sales (K Units) Forecast by Application
11.2.2 Global Insomnia Therapy Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Insomnia Therapy
1.2 Key Market Segments
1.2.1 Insomnia Therapy Segment by Type
1.2.2 Insomnia Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 INSOMNIA THERAPY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Insomnia Therapy Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Insomnia Therapy Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 INSOMNIA THERAPY MARKET COMPETITIVE LANDSCAPE
3.1 Global Insomnia Therapy Sales by Manufacturers (2019-2024)
3.2 Global Insomnia Therapy Revenue Market Share by Manufacturers (2019-2024)
3.3 Insomnia Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Insomnia Therapy Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Insomnia Therapy Sales Sites, Area Served, Product Type
3.6 Insomnia Therapy Market Competitive Situation and Trends
3.6.1 Insomnia Therapy Market Concentration Rate
3.6.2 Global 5 and 10 Largest Insomnia Therapy Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 INSOMNIA THERAPY INDUSTRY CHAIN ANALYSIS
4.1 Insomnia Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF INSOMNIA THERAPY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 INSOMNIA THERAPY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Insomnia Therapy Sales Market Share by Type (2019-2024)
6.3 Global Insomnia Therapy Market Size Market Share by Type (2019-2024)
6.4 Global Insomnia Therapy Price by Type (2019-2024)
7 INSOMNIA THERAPY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Insomnia Therapy Market Sales by Application (2019-2024)
7.3 Global Insomnia Therapy Market Size (M USD) by Application (2019-2024)
7.4 Global Insomnia Therapy Sales Growth Rate by Application (2019-2024)
8 INSOMNIA THERAPY MARKET SEGMENTATION BY REGION
8.1 Global Insomnia Therapy Sales by Region
8.1.1 Global Insomnia Therapy Sales by Region
8.1.2 Global Insomnia Therapy Sales Market Share by Region
8.2 North America
8.2.1 North America Insomnia Therapy Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Insomnia Therapy Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Insomnia Therapy Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Insomnia Therapy Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Insomnia Therapy Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Merck and Co.
9.1.1 Merck and Co. Insomnia Therapy Basic Information
9.1.2 Merck and Co. Insomnia Therapy Product Overview
9.1.3 Merck and Co. Insomnia Therapy Product Market Performance
9.1.4 Merck and Co. Business Overview
9.1.5 Merck and Co. Insomnia Therapy SWOT Analysis
9.1.6 Merck and Co. Recent Developments
9.2 Sanofi
9.2.1 Sanofi Insomnia Therapy Basic Information
9.2.2 Sanofi Insomnia Therapy Product Overview
9.2.3 Sanofi Insomnia Therapy Product Market Performance
9.2.4 Sanofi Business Overview
9.2.5 Sanofi Insomnia Therapy SWOT Analysis
9.2.6 Sanofi Recent Developments
9.3 Pfizer
9.3.1 Pfizer Insomnia Therapy Basic Information
9.3.2 Pfizer Insomnia Therapy Product Overview
9.3.3 Pfizer Insomnia Therapy Product Market Performance
9.3.4 Pfizer Insomnia Therapy SWOT Analysis
9.3.5 Pfizer Business Overview
9.3.6 Pfizer Recent Developments
9.4 Takeda Pharmaceutical Company Ltd.
9.4.1 Takeda Pharmaceutical Company Ltd. Insomnia Therapy Basic Information
9.4.2 Takeda Pharmaceutical Company Ltd. Insomnia Therapy Product Overview
9.4.3 Takeda Pharmaceutical Company Ltd. Insomnia Therapy Product Market Performance
9.4.4 Takeda Pharmaceutical Company Ltd. Business Overview
9.4.5 Takeda Pharmaceutical Company Ltd. Recent Developments
9.5 Purdue Pharmaceuticals L.P.
9.5.1 Purdue Pharmaceuticals L.P. Insomnia Therapy Basic Information
9.5.2 Purdue Pharmaceuticals L.P. Insomnia Therapy Product Overview
9.5.3 Purdue Pharmaceuticals L.P. Insomnia Therapy Product Market Performance
9.5.4 Purdue Pharmaceuticals L.P. Business Overview
9.5.5 Purdue Pharmaceuticals L.P. Recent Developments
9.6 Eisai, Co. Ltd.
9.6.1 Eisai, Co. Ltd. Insomnia Therapy Basic Information
9.6.2 Eisai, Co. Ltd. Insomnia Therapy Product Overview
9.6.3 Eisai, Co. Ltd. Insomnia Therapy Product Market Performance
9.6.4 Eisai, Co. Ltd. Business Overview
9.6.5 Eisai, Co. Ltd. Recent Developments
9.7 Meda Consumer Healthcare
9.7.1 Meda Consumer Healthcare Insomnia Therapy Basic Information
9.7.2 Meda Consumer Healthcare Insomnia Therapy Product Overview
9.7.3 Meda Consumer Healthcare Insomnia Therapy Product Market Performance
9.7.4 Meda Consumer Healthcare Business Overview
9.7.5 Meda Consumer Healthcare Recent Developments
9.8 Pernix Therapeutics
9.8.1 Pernix Therapeutics Insomnia Therapy Basic Information
9.8.2 Pernix Therapeutics Insomnia Therapy Product Overview
9.8.3 Pernix Therapeutics Insomnia Therapy Product Market Performance
9.8.4 Pernix Therapeutics Business Overview
9.8.5 Pernix Therapeutics Recent Developments
9.9 Vanda Pharmaceuticals
9.9.1 Vanda Pharmaceuticals Insomnia Therapy Basic Information
9.9.2 Vanda Pharmaceuticals Insomnia Therapy Product Overview
9.9.3 Vanda Pharmaceuticals Insomnia Therapy Product Market Performance
9.9.4 Vanda Pharmaceuticals Business Overview
9.9.5 Vanda Pharmaceuticals Recent Developments
9.10 ECR Pharmaceuticals
9.10.1 ECR Pharmaceuticals Insomnia Therapy Basic Information
9.10.2 ECR Pharmaceuticals Insomnia Therapy Product Overview
9.10.3 ECR Pharmaceuticals Insomnia Therapy Product Market Performance
9.10.4 ECR Pharmaceuticals Business Overview
9.10.5 ECR Pharmaceuticals Recent Developments
9.11 Fidia Farmaceutici
9.11.1 Fidia Farmaceutici Insomnia Therapy Basic Information
9.11.2 Fidia Farmaceutici Insomnia Therapy Product Overview
9.11.3 Fidia Farmaceutici Insomnia Therapy Product Market Performance
9.11.4 Fidia Farmaceutici Business Overview
9.11.5 Fidia Farmaceutici Recent Developments
9.12 Dainippon Sumitomo
9.12.1 Dainippon Sumitomo Insomnia Therapy Basic Information
9.12.2 Dainippon Sumitomo Insomnia Therapy Product Overview
9.12.3 Dainippon Sumitomo Insomnia Therapy Product Market Performance
9.12.4 Dainippon Sumitomo Business Overview
9.12.5 Dainippon Sumitomo Recent Developments
9.13 Biocodex
9.13.1 Biocodex Insomnia Therapy Basic Information
9.13.2 Biocodex Insomnia Therapy Product Overview
9.13.3 Biocodex Insomnia Therapy Product Market Performance
9.13.4 Biocodex Business Overview
9.13.5 Biocodex Recent Developments
9.14 Eli Lilly and Company
9.14.1 Eli Lilly and Company Insomnia Therapy Basic Information
9.14.2 Eli Lilly and Company Insomnia Therapy Product Overview
9.14.3 Eli Lilly and Company Insomnia Therapy Product Market Performance
9.14.4 Eli Lilly and Company Business Overview
9.14.5 Eli Lilly and Company Recent Developments
9.15 Ebb Therapeutics
9.15.1 Ebb Therapeutics Insomnia Therapy Basic Information
9.15.2 Ebb Therapeutics Insomnia Therapy Product Overview
9.15.3 Ebb Therapeutics Insomnia Therapy Product Market Performance
9.15.4 Ebb Therapeutics Business Overview
9.15.5 Ebb Therapeutics Recent Developments
10 INSOMNIA THERAPY MARKET FORECAST BY REGION
10.1 Global Insomnia Therapy Market Size Forecast
10.2 Global Insomnia Therapy Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Insomnia Therapy Market Size Forecast by Country
10.2.3 Asia Pacific Insomnia Therapy Market Size Forecast by Region
10.2.4 South America Insomnia Therapy Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Insomnia Therapy by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Insomnia Therapy Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Insomnia Therapy by Type (2025-2030)
11.1.2 Global Insomnia Therapy Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Insomnia Therapy by Type (2025-2030)
11.2 Global Insomnia Therapy Market Forecast by Application (2025-2030)
11.2.1 Global Insomnia Therapy Sales (K Units) Forecast by Application
11.2.2 Global Insomnia Therapy Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Insomnia Therapy Market Size Comparison by Region (M USD)
Table 5. Global Insomnia Therapy Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Insomnia Therapy Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Insomnia Therapy Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Insomnia Therapy Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insomnia Therapy as of 2022)
Table 10. Global Market Insomnia Therapy Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Insomnia Therapy Sales Sites and Area Served
Table 12. Manufacturers Insomnia Therapy Product Type
Table 13. Global Insomnia Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Insomnia Therapy
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Insomnia Therapy Market Challenges
Table 22. Global Insomnia Therapy Sales by Type (K Units)
Table 23. Global Insomnia Therapy Market Size by Type (M USD)
Table 24. Global Insomnia Therapy Sales (K Units) by Type (2019-2024)
Table 25. Global Insomnia Therapy Sales Market Share by Type (2019-2024)
Table 26. Global Insomnia Therapy Market Size (M USD) by Type (2019-2024)
Table 27. Global Insomnia Therapy Market Size Share by Type (2019-2024)
Table 28. Global Insomnia Therapy Price (USD/Unit) by Type (2019-2024)
Table 29. Global Insomnia Therapy Sales (K Units) by Application
Table 30. Global Insomnia Therapy Market Size by Application
Table 31. Global Insomnia Therapy Sales by Application (2019-2024) & (K Units)
Table 32. Global Insomnia Therapy Sales Market Share by Application (2019-2024)
Table 33. Global Insomnia Therapy Sales by Application (2019-2024) & (M USD)
Table 34. Global Insomnia Therapy Market Share by Application (2019-2024)
Table 35. Global Insomnia Therapy Sales Growth Rate by Application (2019-2024)
Table 36. Global Insomnia Therapy Sales by Region (2019-2024) & (K Units)
Table 37. Global Insomnia Therapy Sales Market Share by Region (2019-2024)
Table 38. North America Insomnia Therapy Sales by Country (2019-2024) & (K Units)
Table 39. Europe Insomnia Therapy Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Insomnia Therapy Sales by Region (2019-2024) & (K Units)
Table 41. South America Insomnia Therapy Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Insomnia Therapy Sales by Region (2019-2024) & (K Units)
Table 43. Merck and Co. Insomnia Therapy Basic Information
Table 44. Merck and Co. Insomnia Therapy Product Overview
Table 45. Merck and Co. Insomnia Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Merck and Co. Business Overview
Table 47. Merck and Co. Insomnia Therapy SWOT Analysis
Table 48. Merck and Co. Recent Developments
Table 49. Sanofi Insomnia Therapy Basic Information
Table 50. Sanofi Insomnia Therapy Product Overview
Table 51. Sanofi Insomnia Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Sanofi Business Overview
Table 53. Sanofi Insomnia Therapy SWOT Analysis
Table 54. Sanofi Recent Developments
Table 55. Pfizer Insomnia Therapy Basic Information
Table 56. Pfizer Insomnia Therapy Product Overview
Table 57. Pfizer Insomnia Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Pfizer Insomnia Therapy SWOT Analysis
Table 59. Pfizer Business Overview
Table 60. Pfizer Recent Developments
Table 61. Takeda Pharmaceutical Company Ltd. Insomnia Therapy Basic Information
Table 62. Takeda Pharmaceutical Company Ltd. Insomnia Therapy Product Overview
Table 63. Takeda Pharmaceutical Company Ltd. Insomnia Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Takeda Pharmaceutical Company Ltd. Business Overview
Table 65. Takeda Pharmaceutical Company Ltd. Recent Developments
Table 66. Purdue Pharmaceuticals L.P. Insomnia Therapy Basic Information
Table 67. Purdue Pharmaceuticals L.P. Insomnia Therapy Product Overview
Table 68. Purdue Pharmaceuticals L.P. Insomnia Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Purdue Pharmaceuticals L.P. Business Overview
Table 70. Purdue Pharmaceuticals L.P. Recent Developments
Table 71. Eisai, Co. Ltd. Insomnia Therapy Basic Information
Table 72. Eisai, Co. Ltd. Insomnia Therapy Product Overview
Table 73. Eisai, Co. Ltd. Insomnia Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Eisai, Co. Ltd. Business Overview
Table 75. Eisai, Co. Ltd. Recent Developments
Table 76. Meda Consumer Healthcare Insomnia Therapy Basic Information
Table 77. Meda Consumer Healthcare Insomnia Therapy Product Overview
Table 78. Meda Consumer Healthcare Insomnia Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Meda Consumer Healthcare Business Overview
Table 80. Meda Consumer Healthcare Recent Developments
Table 81. Pernix Therapeutics Insomnia Therapy Basic Information
Table 82. Pernix Therapeutics Insomnia Therapy Product Overview
Table 83. Pernix Therapeutics Insomnia Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Pernix Therapeutics Business Overview
Table 85. Pernix Therapeutics Recent Developments
Table 86. Vanda Pharmaceuticals Insomnia Therapy Basic Information
Table 87. Vanda Pharmaceuticals Insomnia Therapy Product Overview
Table 88. Vanda Pharmaceuticals Insomnia Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Vanda Pharmaceuticals Business Overview
Table 90. Vanda Pharmaceuticals Recent Developments
Table 91. ECR Pharmaceuticals Insomnia Therapy Basic Information
Table 92. ECR Pharmaceuticals Insomnia Therapy Product Overview
Table 93. ECR Pharmaceuticals Insomnia Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. ECR Pharmaceuticals Business Overview
Table 95. ECR Pharmaceuticals Recent Developments
Table 96. Fidia Farmaceutici Insomnia Therapy Basic Information
Table 97. Fidia Farmaceutici Insomnia Therapy Product Overview
Table 98. Fidia Farmaceutici Insomnia Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Fidia Farmaceutici Business Overview
Table 100. Fidia Farmaceutici Recent Developments
Table 101. Dainippon Sumitomo Insomnia Therapy Basic Information
Table 102. Dainippon Sumitomo Insomnia Therapy Product Overview
Table 103. Dainippon Sumitomo Insomnia Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Dainippon Sumitomo Business Overview
Table 105. Dainippon Sumitomo Recent Developments
Table 106. Biocodex Insomnia Therapy Basic Information
Table 107. Biocodex Insomnia Therapy Product Overview
Table 108. Biocodex Insomnia Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Biocodex Business Overview
Table 110. Biocodex Recent Developments
Table 111. Eli Lilly and Company Insomnia Therapy Basic Information
Table 112. Eli Lilly and Company Insomnia Therapy Product Overview
Table 113. Eli Lilly and Company Insomnia Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Eli Lilly and Company Business Overview
Table 115. Eli Lilly and Company Recent Developments
Table 116. Ebb Therapeutics Insomnia Therapy Basic Information
Table 117. Ebb Therapeutics Insomnia Therapy Product Overview
Table 118. Ebb Therapeutics Insomnia Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Ebb Therapeutics Business Overview
Table 120. Ebb Therapeutics Recent Developments
Table 121. Global Insomnia Therapy Sales Forecast by Region (2025-2030) & (K Units)
Table 122. Global Insomnia Therapy Market Size Forecast by Region (2025-2030) & (M USD)
Table 123. North America Insomnia Therapy Sales Forecast by Country (2025-2030) & (K Units)
Table 124. North America Insomnia Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 125. Europe Insomnia Therapy Sales Forecast by Country (2025-2030) & (K Units)
Table 126. Europe Insomnia Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 127. Asia Pacific Insomnia Therapy Sales Forecast by Region (2025-2030) & (K Units)
Table 128. Asia Pacific Insomnia Therapy Market Size Forecast by Region (2025-2030) & (M USD)
Table 129. South America Insomnia Therapy Sales Forecast by Country (2025-2030) & (K Units)
Table 130. South America Insomnia Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 131. Middle East and Africa Insomnia Therapy Consumption Forecast by Country (2025-2030) & (Units)
Table 132. Middle East and Africa Insomnia Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 133. Global Insomnia Therapy Sales Forecast by Type (2025-2030) & (K Units)
Table 134. Global Insomnia Therapy Market Size Forecast by Type (2025-2030) & (M USD)
Table 135. Global Insomnia Therapy Price Forecast by Type (2025-2030) & (USD/Unit)
Table 136. Global Insomnia Therapy Sales (K Units) Forecast by Application (2025-2030)
Table 137. Global Insomnia Therapy Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Insomnia Therapy Market Size Comparison by Region (M USD)
Table 5. Global Insomnia Therapy Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Insomnia Therapy Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Insomnia Therapy Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Insomnia Therapy Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insomnia Therapy as of 2022)
Table 10. Global Market Insomnia Therapy Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Insomnia Therapy Sales Sites and Area Served
Table 12. Manufacturers Insomnia Therapy Product Type
Table 13. Global Insomnia Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Insomnia Therapy
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Insomnia Therapy Market Challenges
Table 22. Global Insomnia Therapy Sales by Type (K Units)
Table 23. Global Insomnia Therapy Market Size by Type (M USD)
Table 24. Global Insomnia Therapy Sales (K Units) by Type (2019-2024)
Table 25. Global Insomnia Therapy Sales Market Share by Type (2019-2024)
Table 26. Global Insomnia Therapy Market Size (M USD) by Type (2019-2024)
Table 27. Global Insomnia Therapy Market Size Share by Type (2019-2024)
Table 28. Global Insomnia Therapy Price (USD/Unit) by Type (2019-2024)
Table 29. Global Insomnia Therapy Sales (K Units) by Application
Table 30. Global Insomnia Therapy Market Size by Application
Table 31. Global Insomnia Therapy Sales by Application (2019-2024) & (K Units)
Table 32. Global Insomnia Therapy Sales Market Share by Application (2019-2024)
Table 33. Global Insomnia Therapy Sales by Application (2019-2024) & (M USD)
Table 34. Global Insomnia Therapy Market Share by Application (2019-2024)
Table 35. Global Insomnia Therapy Sales Growth Rate by Application (2019-2024)
Table 36. Global Insomnia Therapy Sales by Region (2019-2024) & (K Units)
Table 37. Global Insomnia Therapy Sales Market Share by Region (2019-2024)
Table 38. North America Insomnia Therapy Sales by Country (2019-2024) & (K Units)
Table 39. Europe Insomnia Therapy Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Insomnia Therapy Sales by Region (2019-2024) & (K Units)
Table 41. South America Insomnia Therapy Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Insomnia Therapy Sales by Region (2019-2024) & (K Units)
Table 43. Merck and Co. Insomnia Therapy Basic Information
Table 44. Merck and Co. Insomnia Therapy Product Overview
Table 45. Merck and Co. Insomnia Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Merck and Co. Business Overview
Table 47. Merck and Co. Insomnia Therapy SWOT Analysis
Table 48. Merck and Co. Recent Developments
Table 49. Sanofi Insomnia Therapy Basic Information
Table 50. Sanofi Insomnia Therapy Product Overview
Table 51. Sanofi Insomnia Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Sanofi Business Overview
Table 53. Sanofi Insomnia Therapy SWOT Analysis
Table 54. Sanofi Recent Developments
Table 55. Pfizer Insomnia Therapy Basic Information
Table 56. Pfizer Insomnia Therapy Product Overview
Table 57. Pfizer Insomnia Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Pfizer Insomnia Therapy SWOT Analysis
Table 59. Pfizer Business Overview
Table 60. Pfizer Recent Developments
Table 61. Takeda Pharmaceutical Company Ltd. Insomnia Therapy Basic Information
Table 62. Takeda Pharmaceutical Company Ltd. Insomnia Therapy Product Overview
Table 63. Takeda Pharmaceutical Company Ltd. Insomnia Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Takeda Pharmaceutical Company Ltd. Business Overview
Table 65. Takeda Pharmaceutical Company Ltd. Recent Developments
Table 66. Purdue Pharmaceuticals L.P. Insomnia Therapy Basic Information
Table 67. Purdue Pharmaceuticals L.P. Insomnia Therapy Product Overview
Table 68. Purdue Pharmaceuticals L.P. Insomnia Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Purdue Pharmaceuticals L.P. Business Overview
Table 70. Purdue Pharmaceuticals L.P. Recent Developments
Table 71. Eisai, Co. Ltd. Insomnia Therapy Basic Information
Table 72. Eisai, Co. Ltd. Insomnia Therapy Product Overview
Table 73. Eisai, Co. Ltd. Insomnia Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Eisai, Co. Ltd. Business Overview
Table 75. Eisai, Co. Ltd. Recent Developments
Table 76. Meda Consumer Healthcare Insomnia Therapy Basic Information
Table 77. Meda Consumer Healthcare Insomnia Therapy Product Overview
Table 78. Meda Consumer Healthcare Insomnia Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Meda Consumer Healthcare Business Overview
Table 80. Meda Consumer Healthcare Recent Developments
Table 81. Pernix Therapeutics Insomnia Therapy Basic Information
Table 82. Pernix Therapeutics Insomnia Therapy Product Overview
Table 83. Pernix Therapeutics Insomnia Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Pernix Therapeutics Business Overview
Table 85. Pernix Therapeutics Recent Developments
Table 86. Vanda Pharmaceuticals Insomnia Therapy Basic Information
Table 87. Vanda Pharmaceuticals Insomnia Therapy Product Overview
Table 88. Vanda Pharmaceuticals Insomnia Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Vanda Pharmaceuticals Business Overview
Table 90. Vanda Pharmaceuticals Recent Developments
Table 91. ECR Pharmaceuticals Insomnia Therapy Basic Information
Table 92. ECR Pharmaceuticals Insomnia Therapy Product Overview
Table 93. ECR Pharmaceuticals Insomnia Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. ECR Pharmaceuticals Business Overview
Table 95. ECR Pharmaceuticals Recent Developments
Table 96. Fidia Farmaceutici Insomnia Therapy Basic Information
Table 97. Fidia Farmaceutici Insomnia Therapy Product Overview
Table 98. Fidia Farmaceutici Insomnia Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Fidia Farmaceutici Business Overview
Table 100. Fidia Farmaceutici Recent Developments
Table 101. Dainippon Sumitomo Insomnia Therapy Basic Information
Table 102. Dainippon Sumitomo Insomnia Therapy Product Overview
Table 103. Dainippon Sumitomo Insomnia Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Dainippon Sumitomo Business Overview
Table 105. Dainippon Sumitomo Recent Developments
Table 106. Biocodex Insomnia Therapy Basic Information
Table 107. Biocodex Insomnia Therapy Product Overview
Table 108. Biocodex Insomnia Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Biocodex Business Overview
Table 110. Biocodex Recent Developments
Table 111. Eli Lilly and Company Insomnia Therapy Basic Information
Table 112. Eli Lilly and Company Insomnia Therapy Product Overview
Table 113. Eli Lilly and Company Insomnia Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Eli Lilly and Company Business Overview
Table 115. Eli Lilly and Company Recent Developments
Table 116. Ebb Therapeutics Insomnia Therapy Basic Information
Table 117. Ebb Therapeutics Insomnia Therapy Product Overview
Table 118. Ebb Therapeutics Insomnia Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Ebb Therapeutics Business Overview
Table 120. Ebb Therapeutics Recent Developments
Table 121. Global Insomnia Therapy Sales Forecast by Region (2025-2030) & (K Units)
Table 122. Global Insomnia Therapy Market Size Forecast by Region (2025-2030) & (M USD)
Table 123. North America Insomnia Therapy Sales Forecast by Country (2025-2030) & (K Units)
Table 124. North America Insomnia Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 125. Europe Insomnia Therapy Sales Forecast by Country (2025-2030) & (K Units)
Table 126. Europe Insomnia Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 127. Asia Pacific Insomnia Therapy Sales Forecast by Region (2025-2030) & (K Units)
Table 128. Asia Pacific Insomnia Therapy Market Size Forecast by Region (2025-2030) & (M USD)
Table 129. South America Insomnia Therapy Sales Forecast by Country (2025-2030) & (K Units)
Table 130. South America Insomnia Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 131. Middle East and Africa Insomnia Therapy Consumption Forecast by Country (2025-2030) & (Units)
Table 132. Middle East and Africa Insomnia Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 133. Global Insomnia Therapy Sales Forecast by Type (2025-2030) & (K Units)
Table 134. Global Insomnia Therapy Market Size Forecast by Type (2025-2030) & (M USD)
Table 135. Global Insomnia Therapy Price Forecast by Type (2025-2030) & (USD/Unit)
Table 136. Global Insomnia Therapy Sales (K Units) Forecast by Application (2025-2030)
Table 137. Global Insomnia Therapy Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Insomnia Therapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Insomnia Therapy Market Size (M USD), 2019-2030
Figure 5. Global Insomnia Therapy Market Size (M USD) (2019-2030)
Figure 6. Global Insomnia Therapy Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Insomnia Therapy Market Size by Country (M USD)
Figure 11. Insomnia Therapy Sales Share by Manufacturers in 2023
Figure 12. Global Insomnia Therapy Revenue Share by Manufacturers in 2023
Figure 13. Insomnia Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Insomnia Therapy Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Insomnia Therapy Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Insomnia Therapy Market Share by Type
Figure 18. Sales Market Share of Insomnia Therapy by Type (2019-2024)
Figure 19. Sales Market Share of Insomnia Therapy by Type in 2023
Figure 20. Market Size Share of Insomnia Therapy by Type (2019-2024)
Figure 21. Market Size Market Share of Insomnia Therapy by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Insomnia Therapy Market Share by Application
Figure 24. Global Insomnia Therapy Sales Market Share by Application (2019-2024)
Figure 25. Global Insomnia Therapy Sales Market Share by Application in 2023
Figure 26. Global Insomnia Therapy Market Share by Application (2019-2024)
Figure 27. Global Insomnia Therapy Market Share by Application in 2023
Figure 28. Global Insomnia Therapy Sales Growth Rate by Application (2019-2024)
Figure 29. Global Insomnia Therapy Sales Market Share by Region (2019-2024)
Figure 30. North America Insomnia Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Insomnia Therapy Sales Market Share by Country in 2023
Figure 32. U.S. Insomnia Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Insomnia Therapy Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Insomnia Therapy Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Insomnia Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Insomnia Therapy Sales Market Share by Country in 2023
Figure 37. Germany Insomnia Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Insomnia Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Insomnia Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Insomnia Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Insomnia Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Insomnia Therapy Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Insomnia Therapy Sales Market Share by Region in 2023
Figure 44. China Insomnia Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Insomnia Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Insomnia Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Insomnia Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Insomnia Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Insomnia Therapy Sales and Growth Rate (K Units)
Figure 50. South America Insomnia Therapy Sales Market Share by Country in 2023
Figure 51. Brazil Insomnia Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Insomnia Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Insomnia Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Insomnia Therapy Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Insomnia Therapy Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Insomnia Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Insomnia Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Insomnia Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Insomnia Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Insomnia Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Insomnia Therapy Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Insomnia Therapy Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Insomnia Therapy Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Insomnia Therapy Market Share Forecast by Type (2025-2030)
Figure 65. Global Insomnia Therapy Sales Forecast by Application (2025-2030)
Figure 66. Global Insomnia Therapy Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Insomnia Therapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Insomnia Therapy Market Size (M USD), 2019-2030
Figure 5. Global Insomnia Therapy Market Size (M USD) (2019-2030)
Figure 6. Global Insomnia Therapy Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Insomnia Therapy Market Size by Country (M USD)
Figure 11. Insomnia Therapy Sales Share by Manufacturers in 2023
Figure 12. Global Insomnia Therapy Revenue Share by Manufacturers in 2023
Figure 13. Insomnia Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Insomnia Therapy Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Insomnia Therapy Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Insomnia Therapy Market Share by Type
Figure 18. Sales Market Share of Insomnia Therapy by Type (2019-2024)
Figure 19. Sales Market Share of Insomnia Therapy by Type in 2023
Figure 20. Market Size Share of Insomnia Therapy by Type (2019-2024)
Figure 21. Market Size Market Share of Insomnia Therapy by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Insomnia Therapy Market Share by Application
Figure 24. Global Insomnia Therapy Sales Market Share by Application (2019-2024)
Figure 25. Global Insomnia Therapy Sales Market Share by Application in 2023
Figure 26. Global Insomnia Therapy Market Share by Application (2019-2024)
Figure 27. Global Insomnia Therapy Market Share by Application in 2023
Figure 28. Global Insomnia Therapy Sales Growth Rate by Application (2019-2024)
Figure 29. Global Insomnia Therapy Sales Market Share by Region (2019-2024)
Figure 30. North America Insomnia Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Insomnia Therapy Sales Market Share by Country in 2023
Figure 32. U.S. Insomnia Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Insomnia Therapy Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Insomnia Therapy Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Insomnia Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Insomnia Therapy Sales Market Share by Country in 2023
Figure 37. Germany Insomnia Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Insomnia Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Insomnia Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Insomnia Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Insomnia Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Insomnia Therapy Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Insomnia Therapy Sales Market Share by Region in 2023
Figure 44. China Insomnia Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Insomnia Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Insomnia Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Insomnia Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Insomnia Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Insomnia Therapy Sales and Growth Rate (K Units)
Figure 50. South America Insomnia Therapy Sales Market Share by Country in 2023
Figure 51. Brazil Insomnia Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Insomnia Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Insomnia Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Insomnia Therapy Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Insomnia Therapy Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Insomnia Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Insomnia Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Insomnia Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Insomnia Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Insomnia Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Insomnia Therapy Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Insomnia Therapy Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Insomnia Therapy Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Insomnia Therapy Market Share Forecast by Type (2025-2030)
Figure 65. Global Insomnia Therapy Sales Forecast by Application (2025-2030)
Figure 66. Global Insomnia Therapy Market Share Forecast by Application (2025-2030)
